Dramatic improvement after tocilizumab of severe COVID ‐19 in a child with sickle cell disease and acute chest syndrome
| Origin | Publisher files allowed on an open archive |
|---|
Journal Articles
American Journal of Hematology
Year : 2020
Harriet Corvol : Connect in order to contact the contributor
https://hal.science/hal-03827781
Submitted on : Monday, July 15, 2024-9:34:55 AM
Last modification on : Friday, November 8, 2024-3:28:08 AM
Dates and versions
Identifiers
- HAL Id : hal-03827781 , version 1
- DOI : 10.1002/ajh.25855
- PUBMED : 32358817
- PUBMEDCENTRAL : PMC7267654
- WOS : 000532999700001
Cite
Marie‐hélène Odièvre, Charles Marcellus, Hubert Ducou Le Pointe, Slimane Allali, Anne‐sophie Romain, et al.. Dramatic improvement after tocilizumab of severe COVID ‐19 in a child with sickle cell disease and acute chest syndrome. American Journal of Hematology, 2020, 95 (8), ⟨10.1002/ajh.25855⟩. ⟨hal-03827781⟩
Collections
176
View
31
Download